Drug Screen 16 With Reflex Confirmation (AMP,BAR,BZO,COC,PCP,THC,OPI,OXY,MD,FEN,BUP,PPX,MEP,TRAM,GABA,CAR), Whole Blood
Use
The Drug Screen 16 test with reflex confirmation is designed to detect the presence of 16 different drug substances and metabolites in whole blood specimens. It is primarily used for drug monitoring and detection programs where blood samples are more appropriate than urine. These substances include illicit drugs, prescription medications, and other controlled substances. The test includes initial presumptive screening followed by confirmatory testing for positive results using more definitive techniques.
Special Instructions
Samples should be transported as instructed, ensuring room temperature for up to 3 days and refrigeration or freezing beyond that period. Confirmatory testing for presumptive positives assists in accurate determination of substance presence, reducing false positives. This test does not distinguish between legally prescribed medications and illicit drug use.
Limitations
The test was developed by LabCorp and its performance characteristics have not been cleared or approved by the FDA. As such, results should be considered as part of a broader clinical assessment. False positives and negatives can occur and reflex confirmation by mass spectrometry is used to improve specificity and sensitivity.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
LOINC Codes
- 72479-9
- 48939-3
- 3376-1
- 42662-7
- 73823-7
- 51692-2
- 42491-1
- 51691-4
- 72402-1
- 72400-5
- 73936-7
- 79139-2
- 72401-3
- 87497-4
- 79148-3
- 87496-6
- 79140-0
Result Turnaround Time
4-10 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Gray-top (sodium fluoride/potassium oxalate) tube, green-top (heparin) tube, or lavender-top (EDTA) tube
Storage Instructions
Submission/transport (<3 days): Room temperature. For storage beyond three days, specimen should be refrigerated or frozen.
